Global Biologics CXO Services Market Growth (Status and Outlook) 2026-2032
The global Biologics CXO Services market size is predicted to grow from US$ 62320 million in 2025 to US$ 111390 million in 2032; it is expected to grow at a CAGR of 8.8% from 2026 to 2032.
Biologics CXO services have gained significant importance as the complexity of biologics and biosimilars development continues to grow. By outsourcing specialized tasks such as clinical trials, process development, and large-scale biologic manufacturing, biopharmaceutical companies can focus on core innovations and strategic growth. This collaboration not only streamlines the drug development pipeline but also ensures compliance with regulatory standards, enhancing the overall efficiency and reducing time-to-market for breakthrough biologic therapies.
United States market for Biologics CXO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biologics CXO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biologics CXO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biologics CXO Services players cover Catalent, Thermo Fisher Scientific, Lonza, Siegfried, Recipharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Biologics CXO Services Industry Forecast” looks at past sales and reviews total world Biologics CXO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biologics CXO Services sales for 2026 through 2032. With Biologics CXO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics CXO Services industry.
This Insight Report provides a comprehensive analysis of the global Biologics CXO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biologics CXO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologics CXO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics CXO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics CXO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics CXO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
The report requires updating with new data and is sent in 48 hours after order is placed.
Biologics CXO services have gained significant importance as the complexity of biologics and biosimilars development continues to grow. By outsourcing specialized tasks such as clinical trials, process development, and large-scale biologic manufacturing, biopharmaceutical companies can focus on core innovations and strategic growth. This collaboration not only streamlines the drug development pipeline but also ensures compliance with regulatory standards, enhancing the overall efficiency and reducing time-to-market for breakthrough biologic therapies.
United States market for Biologics CXO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biologics CXO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biologics CXO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biologics CXO Services players cover Catalent, Thermo Fisher Scientific, Lonza, Siegfried, Recipharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Biologics CXO Services Industry Forecast” looks at past sales and reviews total world Biologics CXO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biologics CXO Services sales for 2026 through 2032. With Biologics CXO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics CXO Services industry.
This Insight Report provides a comprehensive analysis of the global Biologics CXO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biologics CXO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologics CXO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics CXO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics CXO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics CXO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CRO
- CDMO/CMO
- CSO
- API CXO
- FDF CXO
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Catalent
- Thermo Fisher Scientific
- Lonza
- Siegfried
- Recipharm
- Boehringer Ingelheim
- WuXi AppTech
- WuXi Biologics
- Fareva
- Samsung Biologics
- Aenova
- Delpharm
- Strides Pharma
- Piramal
- Famar
- Curia
- Jubilant
- Vetter
- AGC Pharma Chemicals
- Asymchem
- Pharmaron
- Eurofins
- Ascendia Pharmaceuticals
- Ardena
- CPL
- UPM Pharmaceuticals
- FUJIFILM Diosynth Biotechnologies
- Groupe Parima
- TBD Pharmatech
- Avid Bioservices
- NextPharma
- Alcami
- Societal CDMO
- MedPharm
- Euroapi
- BioVectra
- Pfizer CentreOne
- Fermion
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics CXO Services Market Size (2021-2032)
2.1.2 Biologics CXO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biologics CXO Services by Country/Region (2021, 2025 & 2032)
2.2 Biologics CXO Services Segment by Type
2.2.1 CRO
2.2.2 CDMO/CMO
2.2.3 CSO
2.2.4 Biologics CXO Services Market Size by Type
2.2.4.1 Biologics CXO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Biologics CXO Services Market Size Market Share by Type (2021-2026)
2.3 Biologics CXO Services Segment by Application
2.3.1 API CXO
2.3.2 FDF CXO
2.3.3 Other
2.3.4 Biologics CXO Services Market Size by Application
2.3.4.1 Biologics CXO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Biologics CXO Services Market Size Market Share by Application (2021-2026)
3 BIOLOGICS CXO SERVICES MARKET SIZE BY PLAYER
3.1 Biologics CXO Services Market Size Market Share by Player
3.1.1 Global Biologics CXO Services Revenue by Player (2021-2026)
3.1.2 Global Biologics CXO Services Revenue Market Share by Player (2021-2026)
3.2 Global Biologics CXO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGICS CXO SERVICES BY REGION
4.1 Biologics CXO Services Market Size by Region (2021-2026)
4.2 Global Biologics CXO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biologics CXO Services Market Size Growth (2021-2026)
4.4 APAC Biologics CXO Services Market Size Growth (2021-2026)
4.5 Europe Biologics CXO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Biologics CXO Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biologics CXO Services Market Size by Country (2021-2026)
5.2 Americas Biologics CXO Services Market Size by Type (2021-2026)
5.3 Americas Biologics CXO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics CXO Services Market Size by Region (2021-2026)
6.2 APAC Biologics CXO Services Market Size by Type (2021-2026)
6.3 APAC Biologics CXO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologics CXO Services Market Size by Country (2021-2026)
7.2 Europe Biologics CXO Services Market Size by Type (2021-2026)
7.3 Europe Biologics CXO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics CXO Services by Region (2021-2026)
8.2 Middle East & Africa Biologics CXO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Biologics CXO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGICS CXO SERVICES MARKET FORECAST
10.1 Global Biologics CXO Services Forecast by Region (2027-2032)
10.1.1 Global Biologics CXO Services Forecast by Region (2027-2032)
10.1.2 Americas Biologics CXO Services Forecast
10.1.3 APAC Biologics CXO Services Forecast
10.1.4 Europe Biologics CXO Services Forecast
10.1.5 Middle East & Africa Biologics CXO Services Forecast
10.2 Americas Biologics CXO Services Forecast by Country (2027-2032)
10.2.1 United States Market Biologics CXO Services Forecast
10.2.2 Canada Market Biologics CXO Services Forecast
10.2.3 Mexico Market Biologics CXO Services Forecast
10.2.4 Brazil Market Biologics CXO Services Forecast
10.3 APAC Biologics CXO Services Forecast by Region (2027-2032)
10.3.1 China Biologics CXO Services Market Forecast
10.3.2 Japan Market Biologics CXO Services Forecast
10.3.3 Korea Market Biologics CXO Services Forecast
10.3.4 Southeast Asia Market Biologics CXO Services Forecast
10.3.5 India Market Biologics CXO Services Forecast
10.3.6 Australia Market Biologics CXO Services Forecast
10.4 Europe Biologics CXO Services Forecast by Country (2027-2032)
10.4.1 Germany Market Biologics CXO Services Forecast
10.4.2 France Market Biologics CXO Services Forecast
10.4.3 UK Market Biologics CXO Services Forecast
10.4.4 Italy Market Biologics CXO Services Forecast
10.4.5 Russia Market Biologics CXO Services Forecast
10.5 Middle East & Africa Biologics CXO Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Biologics CXO Services Forecast
10.5.2 South Africa Market Biologics CXO Services Forecast
10.5.3 Israel Market Biologics CXO Services Forecast
10.5.4 Turkey Market Biologics CXO Services Forecast
10.6 Global Biologics CXO Services Forecast by Type (2027-2032)
10.7 Global Biologics CXO Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biologics CXO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Catalent
11.1.1 Catalent Company Information
11.1.2 Catalent Biologics CXO Services Product Offered
11.1.3 Catalent Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Catalent Main Business Overview
11.1.5 Catalent Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Biologics CXO Services Product Offered
11.2.3 Thermo Fisher Scientific Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Lonza
11.3.1 Lonza Company Information
11.3.2 Lonza Biologics CXO Services Product Offered
11.3.3 Lonza Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Lonza Main Business Overview
11.3.5 Lonza Latest Developments
11.4 Siegfried
11.4.1 Siegfried Company Information
11.4.2 Siegfried Biologics CXO Services Product Offered
11.4.3 Siegfried Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Siegfried Main Business Overview
11.4.5 Siegfried Latest Developments
11.5 Recipharm
11.5.1 Recipharm Company Information
11.5.2 Recipharm Biologics CXO Services Product Offered
11.5.3 Recipharm Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Recipharm Main Business Overview
11.5.5 Recipharm Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Biologics CXO Services Product Offered
11.6.3 Boehringer Ingelheim Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 WuXi AppTech
11.7.1 WuXi AppTech Company Information
11.7.2 WuXi AppTech Biologics CXO Services Product Offered
11.7.3 WuXi AppTech Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 WuXi AppTech Main Business Overview
11.7.5 WuXi AppTech Latest Developments
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Information
11.8.2 WuXi Biologics Biologics CXO Services Product Offered
11.8.3 WuXi Biologics Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 WuXi Biologics Main Business Overview
11.8.5 WuXi Biologics Latest Developments
11.9 Fareva
11.9.1 Fareva Company Information
11.9.2 Fareva Biologics CXO Services Product Offered
11.9.3 Fareva Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Fareva Main Business Overview
11.9.5 Fareva Latest Developments
11.10 Samsung Biologics
11.10.1 Samsung Biologics Company Information
11.10.2 Samsung Biologics Biologics CXO Services Product Offered
11.10.3 Samsung Biologics Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Samsung Biologics Main Business Overview
11.10.5 Samsung Biologics Latest Developments
11.11 Aenova
11.11.1 Aenova Company Information
11.11.2 Aenova Biologics CXO Services Product Offered
11.11.3 Aenova Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Aenova Main Business Overview
11.11.5 Aenova Latest Developments
11.12 Delpharm
11.12.1 Delpharm Company Information
11.12.2 Delpharm Biologics CXO Services Product Offered
11.12.3 Delpharm Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Delpharm Main Business Overview
11.12.5 Delpharm Latest Developments
11.13 Strides Pharma
11.13.1 Strides Pharma Company Information
11.13.2 Strides Pharma Biologics CXO Services Product Offered
11.13.3 Strides Pharma Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Strides Pharma Main Business Overview
11.13.5 Strides Pharma Latest Developments
11.14 Piramal
11.14.1 Piramal Company Information
11.14.2 Piramal Biologics CXO Services Product Offered
11.14.3 Piramal Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Piramal Main Business Overview
11.14.5 Piramal Latest Developments
11.15 Famar
11.15.1 Famar Company Information
11.15.2 Famar Biologics CXO Services Product Offered
11.15.3 Famar Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Famar Main Business Overview
11.15.5 Famar Latest Developments
11.16 Curia
11.16.1 Curia Company Information
11.16.2 Curia Biologics CXO Services Product Offered
11.16.3 Curia Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Curia Main Business Overview
11.16.5 Curia Latest Developments
11.17 Jubilant
11.17.1 Jubilant Company Information
11.17.2 Jubilant Biologics CXO Services Product Offered
11.17.3 Jubilant Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Jubilant Main Business Overview
11.17.5 Jubilant Latest Developments
11.18 Vetter
11.18.1 Vetter Company Information
11.18.2 Vetter Biologics CXO Services Product Offered
11.18.3 Vetter Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Vetter Main Business Overview
11.18.5 Vetter Latest Developments
11.19 AGC Pharma Chemicals
11.19.1 AGC Pharma Chemicals Company Information
11.19.2 AGC Pharma Chemicals Biologics CXO Services Product Offered
11.19.3 AGC Pharma Chemicals Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 AGC Pharma Chemicals Main Business Overview
11.19.5 AGC Pharma Chemicals Latest Developments
11.20 Asymchem
11.20.1 Asymchem Company Information
11.20.2 Asymchem Biologics CXO Services Product Offered
11.20.3 Asymchem Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Asymchem Main Business Overview
11.20.5 Asymchem Latest Developments
11.21 Pharmaron
11.21.1 Pharmaron Company Information
11.21.2 Pharmaron Biologics CXO Services Product Offered
11.21.3 Pharmaron Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Pharmaron Main Business Overview
11.21.5 Pharmaron Latest Developments
11.22 Eurofins
11.22.1 Eurofins Company Information
11.22.2 Eurofins Biologics CXO Services Product Offered
11.22.3 Eurofins Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Eurofins Main Business Overview
11.22.5 Eurofins Latest Developments
11.23 Ascendia Pharmaceuticals
11.23.1 Ascendia Pharmaceuticals Company Information
11.23.2 Ascendia Pharmaceuticals Biologics CXO Services Product Offered
11.23.3 Ascendia Pharmaceuticals Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Ascendia Pharmaceuticals Main Business Overview
11.23.5 Ascendia Pharmaceuticals Latest Developments
11.24 Ardena
11.24.1 Ardena Company Information
11.24.2 Ardena Biologics CXO Services Product Offered
11.24.3 Ardena Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Ardena Main Business Overview
11.24.5 Ardena Latest Developments
11.25 CPL
11.25.1 CPL Company Information
11.25.2 CPL Biologics CXO Services Product Offered
11.25.3 CPL Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 CPL Main Business Overview
11.25.5 CPL Latest Developments
11.26 UPM Pharmaceuticals
11.26.1 UPM Pharmaceuticals Company Information
11.26.2 UPM Pharmaceuticals Biologics CXO Services Product Offered
11.26.3 UPM Pharmaceuticals Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 UPM Pharmaceuticals Main Business Overview
11.26.5 UPM Pharmaceuticals Latest Developments
11.27 FUJIFILM Diosynth Biotechnologies
11.27.1 FUJIFILM Diosynth Biotechnologies Company Information
11.27.2 FUJIFILM Diosynth Biotechnologies Biologics CXO Services Product Offered
11.27.3 FUJIFILM Diosynth Biotechnologies Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.27.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.28 Groupe Parima
11.28.1 Groupe Parima Company Information
11.28.2 Groupe Parima Biologics CXO Services Product Offered
11.28.3 Groupe Parima Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Groupe Parima Main Business Overview
11.28.5 Groupe Parima Latest Developments
11.29 TBD Pharmatech
11.29.1 TBD Pharmatech Company Information
11.29.2 TBD Pharmatech Biologics CXO Services Product Offered
11.29.3 TBD Pharmatech Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 TBD Pharmatech Main Business Overview
11.29.5 TBD Pharmatech Latest Developments
11.30 Avid Bioservices
11.30.1 Avid Bioservices Company Information
11.30.2 Avid Bioservices Biologics CXO Services Product Offered
11.30.3 Avid Bioservices Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Avid Bioservices Main Business Overview
11.30.5 Avid Bioservices Latest Developments
11.31 NextPharma
11.31.1 NextPharma Company Information
11.31.2 NextPharma Biologics CXO Services Product Offered
11.31.3 NextPharma Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 NextPharma Main Business Overview
11.31.5 NextPharma Latest Developments
11.32 Alcami
11.32.1 Alcami Company Information
11.32.2 Alcami Biologics CXO Services Product Offered
11.32.3 Alcami Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 Alcami Main Business Overview
11.32.5 Alcami Latest Developments
11.33 Societal CDMO
11.33.1 Societal CDMO Company Information
11.33.2 Societal CDMO Biologics CXO Services Product Offered
11.33.3 Societal CDMO Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 Societal CDMO Main Business Overview
11.33.5 Societal CDMO Latest Developments
11.34 MedPharm
11.34.1 MedPharm Company Information
11.34.2 MedPharm Biologics CXO Services Product Offered
11.34.3 MedPharm Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 MedPharm Main Business Overview
11.34.5 MedPharm Latest Developments
11.35 Euroapi
11.35.1 Euroapi Company Information
11.35.2 Euroapi Biologics CXO Services Product Offered
11.35.3 Euroapi Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Euroapi Main Business Overview
11.35.5 Euroapi Latest Developments
11.36 BioVectra
11.36.1 BioVectra Company Information
11.36.2 BioVectra Biologics CXO Services Product Offered
11.36.3 BioVectra Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 BioVectra Main Business Overview
11.36.5 BioVectra Latest Developments
11.37 Pfizer CentreOne
11.37.1 Pfizer CentreOne Company Information
11.37.2 Pfizer CentreOne Biologics CXO Services Product Offered
11.37.3 Pfizer CentreOne Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 Pfizer CentreOne Main Business Overview
11.37.5 Pfizer CentreOne Latest Developments
11.38 Fermion
11.38.1 Fermion Company Information
11.38.2 Fermion Biologics CXO Services Product Offered
11.38.3 Fermion Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Fermion Main Business Overview
11.38.5 Fermion Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics CXO Services Market Size (2021-2032)
2.1.2 Biologics CXO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biologics CXO Services by Country/Region (2021, 2025 & 2032)
2.2 Biologics CXO Services Segment by Type
2.2.1 CRO
2.2.2 CDMO/CMO
2.2.3 CSO
2.2.4 Biologics CXO Services Market Size by Type
2.2.4.1 Biologics CXO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Biologics CXO Services Market Size Market Share by Type (2021-2026)
2.3 Biologics CXO Services Segment by Application
2.3.1 API CXO
2.3.2 FDF CXO
2.3.3 Other
2.3.4 Biologics CXO Services Market Size by Application
2.3.4.1 Biologics CXO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Biologics CXO Services Market Size Market Share by Application (2021-2026)
3 BIOLOGICS CXO SERVICES MARKET SIZE BY PLAYER
3.1 Biologics CXO Services Market Size Market Share by Player
3.1.1 Global Biologics CXO Services Revenue by Player (2021-2026)
3.1.2 Global Biologics CXO Services Revenue Market Share by Player (2021-2026)
3.2 Global Biologics CXO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGICS CXO SERVICES BY REGION
4.1 Biologics CXO Services Market Size by Region (2021-2026)
4.2 Global Biologics CXO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biologics CXO Services Market Size Growth (2021-2026)
4.4 APAC Biologics CXO Services Market Size Growth (2021-2026)
4.5 Europe Biologics CXO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Biologics CXO Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biologics CXO Services Market Size by Country (2021-2026)
5.2 Americas Biologics CXO Services Market Size by Type (2021-2026)
5.3 Americas Biologics CXO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics CXO Services Market Size by Region (2021-2026)
6.2 APAC Biologics CXO Services Market Size by Type (2021-2026)
6.3 APAC Biologics CXO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologics CXO Services Market Size by Country (2021-2026)
7.2 Europe Biologics CXO Services Market Size by Type (2021-2026)
7.3 Europe Biologics CXO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics CXO Services by Region (2021-2026)
8.2 Middle East & Africa Biologics CXO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Biologics CXO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGICS CXO SERVICES MARKET FORECAST
10.1 Global Biologics CXO Services Forecast by Region (2027-2032)
10.1.1 Global Biologics CXO Services Forecast by Region (2027-2032)
10.1.2 Americas Biologics CXO Services Forecast
10.1.3 APAC Biologics CXO Services Forecast
10.1.4 Europe Biologics CXO Services Forecast
10.1.5 Middle East & Africa Biologics CXO Services Forecast
10.2 Americas Biologics CXO Services Forecast by Country (2027-2032)
10.2.1 United States Market Biologics CXO Services Forecast
10.2.2 Canada Market Biologics CXO Services Forecast
10.2.3 Mexico Market Biologics CXO Services Forecast
10.2.4 Brazil Market Biologics CXO Services Forecast
10.3 APAC Biologics CXO Services Forecast by Region (2027-2032)
10.3.1 China Biologics CXO Services Market Forecast
10.3.2 Japan Market Biologics CXO Services Forecast
10.3.3 Korea Market Biologics CXO Services Forecast
10.3.4 Southeast Asia Market Biologics CXO Services Forecast
10.3.5 India Market Biologics CXO Services Forecast
10.3.6 Australia Market Biologics CXO Services Forecast
10.4 Europe Biologics CXO Services Forecast by Country (2027-2032)
10.4.1 Germany Market Biologics CXO Services Forecast
10.4.2 France Market Biologics CXO Services Forecast
10.4.3 UK Market Biologics CXO Services Forecast
10.4.4 Italy Market Biologics CXO Services Forecast
10.4.5 Russia Market Biologics CXO Services Forecast
10.5 Middle East & Africa Biologics CXO Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Biologics CXO Services Forecast
10.5.2 South Africa Market Biologics CXO Services Forecast
10.5.3 Israel Market Biologics CXO Services Forecast
10.5.4 Turkey Market Biologics CXO Services Forecast
10.6 Global Biologics CXO Services Forecast by Type (2027-2032)
10.7 Global Biologics CXO Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biologics CXO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Catalent
11.1.1 Catalent Company Information
11.1.2 Catalent Biologics CXO Services Product Offered
11.1.3 Catalent Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Catalent Main Business Overview
11.1.5 Catalent Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Biologics CXO Services Product Offered
11.2.3 Thermo Fisher Scientific Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Lonza
11.3.1 Lonza Company Information
11.3.2 Lonza Biologics CXO Services Product Offered
11.3.3 Lonza Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Lonza Main Business Overview
11.3.5 Lonza Latest Developments
11.4 Siegfried
11.4.1 Siegfried Company Information
11.4.2 Siegfried Biologics CXO Services Product Offered
11.4.3 Siegfried Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Siegfried Main Business Overview
11.4.5 Siegfried Latest Developments
11.5 Recipharm
11.5.1 Recipharm Company Information
11.5.2 Recipharm Biologics CXO Services Product Offered
11.5.3 Recipharm Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Recipharm Main Business Overview
11.5.5 Recipharm Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Biologics CXO Services Product Offered
11.6.3 Boehringer Ingelheim Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 WuXi AppTech
11.7.1 WuXi AppTech Company Information
11.7.2 WuXi AppTech Biologics CXO Services Product Offered
11.7.3 WuXi AppTech Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 WuXi AppTech Main Business Overview
11.7.5 WuXi AppTech Latest Developments
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Information
11.8.2 WuXi Biologics Biologics CXO Services Product Offered
11.8.3 WuXi Biologics Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 WuXi Biologics Main Business Overview
11.8.5 WuXi Biologics Latest Developments
11.9 Fareva
11.9.1 Fareva Company Information
11.9.2 Fareva Biologics CXO Services Product Offered
11.9.3 Fareva Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Fareva Main Business Overview
11.9.5 Fareva Latest Developments
11.10 Samsung Biologics
11.10.1 Samsung Biologics Company Information
11.10.2 Samsung Biologics Biologics CXO Services Product Offered
11.10.3 Samsung Biologics Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Samsung Biologics Main Business Overview
11.10.5 Samsung Biologics Latest Developments
11.11 Aenova
11.11.1 Aenova Company Information
11.11.2 Aenova Biologics CXO Services Product Offered
11.11.3 Aenova Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Aenova Main Business Overview
11.11.5 Aenova Latest Developments
11.12 Delpharm
11.12.1 Delpharm Company Information
11.12.2 Delpharm Biologics CXO Services Product Offered
11.12.3 Delpharm Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Delpharm Main Business Overview
11.12.5 Delpharm Latest Developments
11.13 Strides Pharma
11.13.1 Strides Pharma Company Information
11.13.2 Strides Pharma Biologics CXO Services Product Offered
11.13.3 Strides Pharma Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Strides Pharma Main Business Overview
11.13.5 Strides Pharma Latest Developments
11.14 Piramal
11.14.1 Piramal Company Information
11.14.2 Piramal Biologics CXO Services Product Offered
11.14.3 Piramal Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Piramal Main Business Overview
11.14.5 Piramal Latest Developments
11.15 Famar
11.15.1 Famar Company Information
11.15.2 Famar Biologics CXO Services Product Offered
11.15.3 Famar Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Famar Main Business Overview
11.15.5 Famar Latest Developments
11.16 Curia
11.16.1 Curia Company Information
11.16.2 Curia Biologics CXO Services Product Offered
11.16.3 Curia Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Curia Main Business Overview
11.16.5 Curia Latest Developments
11.17 Jubilant
11.17.1 Jubilant Company Information
11.17.2 Jubilant Biologics CXO Services Product Offered
11.17.3 Jubilant Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Jubilant Main Business Overview
11.17.5 Jubilant Latest Developments
11.18 Vetter
11.18.1 Vetter Company Information
11.18.2 Vetter Biologics CXO Services Product Offered
11.18.3 Vetter Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Vetter Main Business Overview
11.18.5 Vetter Latest Developments
11.19 AGC Pharma Chemicals
11.19.1 AGC Pharma Chemicals Company Information
11.19.2 AGC Pharma Chemicals Biologics CXO Services Product Offered
11.19.3 AGC Pharma Chemicals Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 AGC Pharma Chemicals Main Business Overview
11.19.5 AGC Pharma Chemicals Latest Developments
11.20 Asymchem
11.20.1 Asymchem Company Information
11.20.2 Asymchem Biologics CXO Services Product Offered
11.20.3 Asymchem Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Asymchem Main Business Overview
11.20.5 Asymchem Latest Developments
11.21 Pharmaron
11.21.1 Pharmaron Company Information
11.21.2 Pharmaron Biologics CXO Services Product Offered
11.21.3 Pharmaron Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Pharmaron Main Business Overview
11.21.5 Pharmaron Latest Developments
11.22 Eurofins
11.22.1 Eurofins Company Information
11.22.2 Eurofins Biologics CXO Services Product Offered
11.22.3 Eurofins Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Eurofins Main Business Overview
11.22.5 Eurofins Latest Developments
11.23 Ascendia Pharmaceuticals
11.23.1 Ascendia Pharmaceuticals Company Information
11.23.2 Ascendia Pharmaceuticals Biologics CXO Services Product Offered
11.23.3 Ascendia Pharmaceuticals Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Ascendia Pharmaceuticals Main Business Overview
11.23.5 Ascendia Pharmaceuticals Latest Developments
11.24 Ardena
11.24.1 Ardena Company Information
11.24.2 Ardena Biologics CXO Services Product Offered
11.24.3 Ardena Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Ardena Main Business Overview
11.24.5 Ardena Latest Developments
11.25 CPL
11.25.1 CPL Company Information
11.25.2 CPL Biologics CXO Services Product Offered
11.25.3 CPL Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 CPL Main Business Overview
11.25.5 CPL Latest Developments
11.26 UPM Pharmaceuticals
11.26.1 UPM Pharmaceuticals Company Information
11.26.2 UPM Pharmaceuticals Biologics CXO Services Product Offered
11.26.3 UPM Pharmaceuticals Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 UPM Pharmaceuticals Main Business Overview
11.26.5 UPM Pharmaceuticals Latest Developments
11.27 FUJIFILM Diosynth Biotechnologies
11.27.1 FUJIFILM Diosynth Biotechnologies Company Information
11.27.2 FUJIFILM Diosynth Biotechnologies Biologics CXO Services Product Offered
11.27.3 FUJIFILM Diosynth Biotechnologies Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.27.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.28 Groupe Parima
11.28.1 Groupe Parima Company Information
11.28.2 Groupe Parima Biologics CXO Services Product Offered
11.28.3 Groupe Parima Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Groupe Parima Main Business Overview
11.28.5 Groupe Parima Latest Developments
11.29 TBD Pharmatech
11.29.1 TBD Pharmatech Company Information
11.29.2 TBD Pharmatech Biologics CXO Services Product Offered
11.29.3 TBD Pharmatech Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 TBD Pharmatech Main Business Overview
11.29.5 TBD Pharmatech Latest Developments
11.30 Avid Bioservices
11.30.1 Avid Bioservices Company Information
11.30.2 Avid Bioservices Biologics CXO Services Product Offered
11.30.3 Avid Bioservices Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Avid Bioservices Main Business Overview
11.30.5 Avid Bioservices Latest Developments
11.31 NextPharma
11.31.1 NextPharma Company Information
11.31.2 NextPharma Biologics CXO Services Product Offered
11.31.3 NextPharma Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 NextPharma Main Business Overview
11.31.5 NextPharma Latest Developments
11.32 Alcami
11.32.1 Alcami Company Information
11.32.2 Alcami Biologics CXO Services Product Offered
11.32.3 Alcami Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 Alcami Main Business Overview
11.32.5 Alcami Latest Developments
11.33 Societal CDMO
11.33.1 Societal CDMO Company Information
11.33.2 Societal CDMO Biologics CXO Services Product Offered
11.33.3 Societal CDMO Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 Societal CDMO Main Business Overview
11.33.5 Societal CDMO Latest Developments
11.34 MedPharm
11.34.1 MedPharm Company Information
11.34.2 MedPharm Biologics CXO Services Product Offered
11.34.3 MedPharm Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 MedPharm Main Business Overview
11.34.5 MedPharm Latest Developments
11.35 Euroapi
11.35.1 Euroapi Company Information
11.35.2 Euroapi Biologics CXO Services Product Offered
11.35.3 Euroapi Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Euroapi Main Business Overview
11.35.5 Euroapi Latest Developments
11.36 BioVectra
11.36.1 BioVectra Company Information
11.36.2 BioVectra Biologics CXO Services Product Offered
11.36.3 BioVectra Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 BioVectra Main Business Overview
11.36.5 BioVectra Latest Developments
11.37 Pfizer CentreOne
11.37.1 Pfizer CentreOne Company Information
11.37.2 Pfizer CentreOne Biologics CXO Services Product Offered
11.37.3 Pfizer CentreOne Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 Pfizer CentreOne Main Business Overview
11.37.5 Pfizer CentreOne Latest Developments
11.38 Fermion
11.38.1 Fermion Company Information
11.38.2 Fermion Biologics CXO Services Product Offered
11.38.3 Fermion Biologics CXO Services Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Fermion Main Business Overview
11.38.5 Fermion Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologics CXO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biologics CXO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CRO
Table 4. Major Players of CDMO/CMO
Table 5. Major Players of CSO
Table 6. Biologics CXO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Biologics CXO Services Market Size Market Share by Type (2021-2026)
Table 9. Biologics CXO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Biologics CXO Services Market Size Market Share by Application (2021-2026)
Table 12. Global Biologics CXO Services Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Biologics CXO Services Revenue Market Share by Player (2021-2026)
Table 14. Biologics CXO Services Key Players Head office and Products Offered
Table 15. Biologics CXO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Biologics CXO Services Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Biologics CXO Services Market Size Market Share by Region (2021-2026)
Table 20. Global Biologics CXO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Biologics CXO Services Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Biologics CXO Services Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Biologics CXO Services Market Size Market Share by Country (2021-2026)
Table 24. Americas Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Biologics CXO Services Market Size Market Share by Type (2021-2026)
Table 26. Americas Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Biologics CXO Services Market Size Market Share by Application (2021-2026)
Table 28. APAC Biologics CXO Services Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Biologics CXO Services Market Size Market Share by Region (2021-2026)
Table 30. APAC Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Biologics CXO Services Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Biologics CXO Services Market Size Market Share by Country (2021-2026)
Table 34. Europe Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Biologics CXO Services Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Biologics CXO Services
Table 40. Key Market Challenges & Risks of Biologics CXO Services
Table 41. Key Industry Trends of Biologics CXO Services
Table 42. Global Biologics CXO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Biologics CXO Services Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Biologics CXO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Biologics CXO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Catalent Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 47. Catalent Biologics CXO Services Product Offered
Table 48. Catalent Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Catalent Main Business
Table 50. Catalent Latest Developments
Table 51. Thermo Fisher Scientific Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Biologics CXO Services Product Offered
Table 53. Thermo Fisher Scientific Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Thermo Fisher Scientific Main Business
Table 55. Thermo Fisher Scientific Latest Developments
Table 56. Lonza Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 57. Lonza Biologics CXO Services Product Offered
Table 58. Lonza Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Lonza Main Business
Table 60. Lonza Latest Developments
Table 61. Siegfried Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 62. Siegfried Biologics CXO Services Product Offered
Table 63. Siegfried Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Siegfried Main Business
Table 65. Siegfried Latest Developments
Table 66. Recipharm Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 67. Recipharm Biologics CXO Services Product Offered
Table 68. Recipharm Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Recipharm Main Business
Table 70. Recipharm Latest Developments
Table 71. Boehringer Ingelheim Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 72. Boehringer Ingelheim Biologics CXO Services Product Offered
Table 73. Boehringer Ingelheim Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Boehringer Ingelheim Main Business
Table 75. Boehringer Ingelheim Latest Developments
Table 76. WuXi AppTech Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 77. WuXi AppTech Biologics CXO Services Product Offered
Table 78. WuXi AppTech Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. WuXi AppTech Main Business
Table 80. WuXi AppTech Latest Developments
Table 81. WuXi Biologics Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 82. WuXi Biologics Biologics CXO Services Product Offered
Table 83. WuXi Biologics Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. WuXi Biologics Main Business
Table 85. WuXi Biologics Latest Developments
Table 86. Fareva Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 87. Fareva Biologics CXO Services Product Offered
Table 88. Fareva Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Fareva Main Business
Table 90. Fareva Latest Developments
Table 91. Samsung Biologics Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 92. Samsung Biologics Biologics CXO Services Product Offered
Table 93. Samsung Biologics Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Samsung Biologics Main Business
Table 95. Samsung Biologics Latest Developments
Table 96. Aenova Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 97. Aenova Biologics CXO Services Product Offered
Table 98. Aenova Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Aenova Main Business
Table 100. Aenova Latest Developments
Table 101. Delpharm Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 102. Delpharm Biologics CXO Services Product Offered
Table 103. Delpharm Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Delpharm Main Business
Table 105. Delpharm Latest Developments
Table 106. Strides Pharma Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 107. Strides Pharma Biologics CXO Services Product Offered
Table 108. Strides Pharma Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Strides Pharma Main Business
Table 110. Strides Pharma Latest Developments
Table 111. Piramal Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 112. Piramal Biologics CXO Services Product Offered
Table 113. Piramal Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Piramal Main Business
Table 115. Piramal Latest Developments
Table 116. Famar Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 117. Famar Biologics CXO Services Product Offered
Table 118. Famar Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Famar Main Business
Table 120. Famar Latest Developments
Table 121. Curia Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 122. Curia Biologics CXO Services Product Offered
Table 123. Curia Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Curia Main Business
Table 125. Curia Latest Developments
Table 126. Jubilant Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 127. Jubilant Biologics CXO Services Product Offered
Table 128. Jubilant Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Jubilant Main Business
Table 130. Jubilant Latest Developments
Table 131. Vetter Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 132. Vetter Biologics CXO Services Product Offered
Table 133. Vetter Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Vetter Main Business
Table 135. Vetter Latest Developments
Table 136. AGC Pharma Chemicals Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 137. AGC Pharma Chemicals Biologics CXO Services Product Offered
Table 138. AGC Pharma Chemicals Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. AGC Pharma Chemicals Main Business
Table 140. AGC Pharma Chemicals Latest Developments
Table 141. Asymchem Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 142. Asymchem Biologics CXO Services Product Offered
Table 143. Asymchem Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Asymchem Main Business
Table 145. Asymchem Latest Developments
Table 146. Pharmaron Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 147. Pharmaron Biologics CXO Services Product Offered
Table 148. Pharmaron Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Pharmaron Main Business
Table 150. Pharmaron Latest Developments
Table 151. Eurofins Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 152. Eurofins Biologics CXO Services Product Offered
Table 153. Eurofins Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Eurofins Main Business
Table 155. Eurofins Latest Developments
Table 156. Ascendia Pharmaceuticals Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 157. Ascendia Pharmaceuticals Biologics CXO Services Product Offered
Table 158. Ascendia Pharmaceuticals Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Ascendia Pharmaceuticals Main Business
Table 160. Ascendia Pharmaceuticals Latest Developments
Table 161. Ardena Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 162. Ardena Biologics CXO Services Product Offered
Table 163. Ardena Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Ardena Main Business
Table 165. Ardena Latest Developments
Table 166. CPL Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 167. CPL Biologics CXO Services Product Offered
Table 168. CPL Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. CPL Main Business
Table 170. CPL Latest Developments
Table 171. UPM Pharmaceuticals Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 172. UPM Pharmaceuticals Biologics CXO Services Product Offered
Table 173. UPM Pharmaceuticals Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. UPM Pharmaceuticals Main Business
Table 175. UPM Pharmaceuticals Latest Developments
Table 176. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 177. FUJIFILM Diosynth Biotechnologies Biologics CXO Services Product Offered
Table 178. FUJIFILM Diosynth Biotechnologies Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. FUJIFILM Diosynth Biotechnologies Main Business
Table 180. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 181. Groupe Parima Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 182. Groupe Parima Biologics CXO Services Product Offered
Table 183. Groupe Parima Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 184. Groupe Parima Main Business
Table 185. Groupe Parima Latest Developments
Table 186. TBD Pharmatech Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 187. TBD Pharmatech Biologics CXO Services Product Offered
Table 188. TBD Pharmatech Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 189. TBD Pharmatech Main Business
Table 190. TBD Pharmatech Latest Developments
Table 191. Avid Bioservices Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 192. Avid Bioservices Biologics CXO Services Product Offered
Table 193. Avid Bioservices Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 194. Avid Bioservices Main Business
Table 195. Avid Bioservices Latest Developments
Table 196. NextPharma Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 197. NextPharma Biologics CXO Services Product Offered
Table 198. NextPharma Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 199. NextPharma Main Business
Table 200. NextPharma Latest Developments
Table 201. Alcami Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 202. Alcami Biologics CXO Services Product Offered
Table 203. Alcami Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 204. Alcami Main Business
Table 205. Alcami Latest Developments
Table 206. Societal CDMO Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 207. Societal CDMO Biologics CXO Services Product Offered
Table 208. Societal CDMO Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 209. Societal CDMO Main Business
Table 210. Societal CDMO Latest Developments
Table 211. MedPharm Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 212. MedPharm Biologics CXO Services Product Offered
Table 213. MedPharm Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 214. MedPharm Main Business
Table 215. MedPharm Latest Developments
Table 216. Euroapi Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 217. Euroapi Biologics CXO Services Product Offered
Table 218. Euroapi Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 219. Euroapi Main Business
Table 220. Euroapi Latest Developments
Table 221. BioVectra Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 222. BioVectra Biologics CXO Services Product Offered
Table 223. BioVectra Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 224. BioVectra Main Business
Table 225. BioVectra Latest Developments
Table 226. Pfizer CentreOne Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 227. Pfizer CentreOne Biologics CXO Services Product Offered
Table 228. Pfizer CentreOne Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 229. Pfizer CentreOne Main Business
Table 230. Pfizer CentreOne Latest Developments
Table 231. Fermion Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 232. Fermion Biologics CXO Services Product Offered
Table 233. Fermion Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 234. Fermion Main Business
Table 235. Fermion Latest Developments
Table 1. Biologics CXO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biologics CXO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CRO
Table 4. Major Players of CDMO/CMO
Table 5. Major Players of CSO
Table 6. Biologics CXO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Biologics CXO Services Market Size Market Share by Type (2021-2026)
Table 9. Biologics CXO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Biologics CXO Services Market Size Market Share by Application (2021-2026)
Table 12. Global Biologics CXO Services Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Biologics CXO Services Revenue Market Share by Player (2021-2026)
Table 14. Biologics CXO Services Key Players Head office and Products Offered
Table 15. Biologics CXO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Biologics CXO Services Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Biologics CXO Services Market Size Market Share by Region (2021-2026)
Table 20. Global Biologics CXO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Biologics CXO Services Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Biologics CXO Services Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Biologics CXO Services Market Size Market Share by Country (2021-2026)
Table 24. Americas Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Biologics CXO Services Market Size Market Share by Type (2021-2026)
Table 26. Americas Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Biologics CXO Services Market Size Market Share by Application (2021-2026)
Table 28. APAC Biologics CXO Services Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Biologics CXO Services Market Size Market Share by Region (2021-2026)
Table 30. APAC Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Biologics CXO Services Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Biologics CXO Services Market Size Market Share by Country (2021-2026)
Table 34. Europe Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Biologics CXO Services Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biologics CXO Services Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biologics CXO Services Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Biologics CXO Services
Table 40. Key Market Challenges & Risks of Biologics CXO Services
Table 41. Key Industry Trends of Biologics CXO Services
Table 42. Global Biologics CXO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Biologics CXO Services Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Biologics CXO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Biologics CXO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Catalent Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 47. Catalent Biologics CXO Services Product Offered
Table 48. Catalent Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Catalent Main Business
Table 50. Catalent Latest Developments
Table 51. Thermo Fisher Scientific Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Biologics CXO Services Product Offered
Table 53. Thermo Fisher Scientific Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Thermo Fisher Scientific Main Business
Table 55. Thermo Fisher Scientific Latest Developments
Table 56. Lonza Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 57. Lonza Biologics CXO Services Product Offered
Table 58. Lonza Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Lonza Main Business
Table 60. Lonza Latest Developments
Table 61. Siegfried Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 62. Siegfried Biologics CXO Services Product Offered
Table 63. Siegfried Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Siegfried Main Business
Table 65. Siegfried Latest Developments
Table 66. Recipharm Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 67. Recipharm Biologics CXO Services Product Offered
Table 68. Recipharm Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Recipharm Main Business
Table 70. Recipharm Latest Developments
Table 71. Boehringer Ingelheim Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 72. Boehringer Ingelheim Biologics CXO Services Product Offered
Table 73. Boehringer Ingelheim Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Boehringer Ingelheim Main Business
Table 75. Boehringer Ingelheim Latest Developments
Table 76. WuXi AppTech Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 77. WuXi AppTech Biologics CXO Services Product Offered
Table 78. WuXi AppTech Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. WuXi AppTech Main Business
Table 80. WuXi AppTech Latest Developments
Table 81. WuXi Biologics Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 82. WuXi Biologics Biologics CXO Services Product Offered
Table 83. WuXi Biologics Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. WuXi Biologics Main Business
Table 85. WuXi Biologics Latest Developments
Table 86. Fareva Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 87. Fareva Biologics CXO Services Product Offered
Table 88. Fareva Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Fareva Main Business
Table 90. Fareva Latest Developments
Table 91. Samsung Biologics Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 92. Samsung Biologics Biologics CXO Services Product Offered
Table 93. Samsung Biologics Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Samsung Biologics Main Business
Table 95. Samsung Biologics Latest Developments
Table 96. Aenova Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 97. Aenova Biologics CXO Services Product Offered
Table 98. Aenova Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Aenova Main Business
Table 100. Aenova Latest Developments
Table 101. Delpharm Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 102. Delpharm Biologics CXO Services Product Offered
Table 103. Delpharm Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Delpharm Main Business
Table 105. Delpharm Latest Developments
Table 106. Strides Pharma Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 107. Strides Pharma Biologics CXO Services Product Offered
Table 108. Strides Pharma Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Strides Pharma Main Business
Table 110. Strides Pharma Latest Developments
Table 111. Piramal Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 112. Piramal Biologics CXO Services Product Offered
Table 113. Piramal Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Piramal Main Business
Table 115. Piramal Latest Developments
Table 116. Famar Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 117. Famar Biologics CXO Services Product Offered
Table 118. Famar Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Famar Main Business
Table 120. Famar Latest Developments
Table 121. Curia Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 122. Curia Biologics CXO Services Product Offered
Table 123. Curia Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Curia Main Business
Table 125. Curia Latest Developments
Table 126. Jubilant Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 127. Jubilant Biologics CXO Services Product Offered
Table 128. Jubilant Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Jubilant Main Business
Table 130. Jubilant Latest Developments
Table 131. Vetter Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 132. Vetter Biologics CXO Services Product Offered
Table 133. Vetter Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Vetter Main Business
Table 135. Vetter Latest Developments
Table 136. AGC Pharma Chemicals Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 137. AGC Pharma Chemicals Biologics CXO Services Product Offered
Table 138. AGC Pharma Chemicals Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. AGC Pharma Chemicals Main Business
Table 140. AGC Pharma Chemicals Latest Developments
Table 141. Asymchem Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 142. Asymchem Biologics CXO Services Product Offered
Table 143. Asymchem Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Asymchem Main Business
Table 145. Asymchem Latest Developments
Table 146. Pharmaron Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 147. Pharmaron Biologics CXO Services Product Offered
Table 148. Pharmaron Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Pharmaron Main Business
Table 150. Pharmaron Latest Developments
Table 151. Eurofins Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 152. Eurofins Biologics CXO Services Product Offered
Table 153. Eurofins Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Eurofins Main Business
Table 155. Eurofins Latest Developments
Table 156. Ascendia Pharmaceuticals Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 157. Ascendia Pharmaceuticals Biologics CXO Services Product Offered
Table 158. Ascendia Pharmaceuticals Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Ascendia Pharmaceuticals Main Business
Table 160. Ascendia Pharmaceuticals Latest Developments
Table 161. Ardena Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 162. Ardena Biologics CXO Services Product Offered
Table 163. Ardena Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Ardena Main Business
Table 165. Ardena Latest Developments
Table 166. CPL Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 167. CPL Biologics CXO Services Product Offered
Table 168. CPL Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. CPL Main Business
Table 170. CPL Latest Developments
Table 171. UPM Pharmaceuticals Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 172. UPM Pharmaceuticals Biologics CXO Services Product Offered
Table 173. UPM Pharmaceuticals Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. UPM Pharmaceuticals Main Business
Table 175. UPM Pharmaceuticals Latest Developments
Table 176. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 177. FUJIFILM Diosynth Biotechnologies Biologics CXO Services Product Offered
Table 178. FUJIFILM Diosynth Biotechnologies Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. FUJIFILM Diosynth Biotechnologies Main Business
Table 180. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 181. Groupe Parima Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 182. Groupe Parima Biologics CXO Services Product Offered
Table 183. Groupe Parima Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 184. Groupe Parima Main Business
Table 185. Groupe Parima Latest Developments
Table 186. TBD Pharmatech Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 187. TBD Pharmatech Biologics CXO Services Product Offered
Table 188. TBD Pharmatech Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 189. TBD Pharmatech Main Business
Table 190. TBD Pharmatech Latest Developments
Table 191. Avid Bioservices Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 192. Avid Bioservices Biologics CXO Services Product Offered
Table 193. Avid Bioservices Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 194. Avid Bioservices Main Business
Table 195. Avid Bioservices Latest Developments
Table 196. NextPharma Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 197. NextPharma Biologics CXO Services Product Offered
Table 198. NextPharma Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 199. NextPharma Main Business
Table 200. NextPharma Latest Developments
Table 201. Alcami Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 202. Alcami Biologics CXO Services Product Offered
Table 203. Alcami Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 204. Alcami Main Business
Table 205. Alcami Latest Developments
Table 206. Societal CDMO Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 207. Societal CDMO Biologics CXO Services Product Offered
Table 208. Societal CDMO Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 209. Societal CDMO Main Business
Table 210. Societal CDMO Latest Developments
Table 211. MedPharm Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 212. MedPharm Biologics CXO Services Product Offered
Table 213. MedPharm Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 214. MedPharm Main Business
Table 215. MedPharm Latest Developments
Table 216. Euroapi Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 217. Euroapi Biologics CXO Services Product Offered
Table 218. Euroapi Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 219. Euroapi Main Business
Table 220. Euroapi Latest Developments
Table 221. BioVectra Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 222. BioVectra Biologics CXO Services Product Offered
Table 223. BioVectra Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 224. BioVectra Main Business
Table 225. BioVectra Latest Developments
Table 226. Pfizer CentreOne Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 227. Pfizer CentreOne Biologics CXO Services Product Offered
Table 228. Pfizer CentreOne Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 229. Pfizer CentreOne Main Business
Table 230. Pfizer CentreOne Latest Developments
Table 231. Fermion Details, Company Type, Biologics CXO Services Area Served and Its Competitors
Table 232. Fermion Biologics CXO Services Product Offered
Table 233. Fermion Biologics CXO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 234. Fermion Main Business
Table 235. Fermion Latest Developments
LIST OF FIGURES
Figure 1. Biologics CXO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics CXO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biologics CXO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biologics CXO Services Sales Market Share by Country/Region (2025)
Figure 8. Biologics CXO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biologics CXO Services Market Size Market Share by Type in 2025
Figure 10. Biologics CXO Services in API CXO
Figure 11. Global Biologics CXO Services Market: API CXO (2021-2026) & ($ millions)
Figure 12. Biologics CXO Services in FDF CXO
Figure 13. Global Biologics CXO Services Market: FDF CXO (2021-2026) & ($ millions)
Figure 14. Biologics CXO Services in Other
Figure 15. Global Biologics CXO Services Market: Other (2021-2026) & ($ millions)
Figure 16. Global Biologics CXO Services Market Size Market Share by Application in 2025
Figure 17. Global Biologics CXO Services Revenue Market Share by Player in 2025
Figure 18. Global Biologics CXO Services Market Size Market Share by Region (2021-2026)
Figure 19. Americas Biologics CXO Services Market Size 2021-2026 ($ millions)
Figure 20. APAC Biologics CXO Services Market Size 2021-2026 ($ millions)
Figure 21. Europe Biologics CXO Services Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Biologics CXO Services Market Size 2021-2026 ($ millions)
Figure 23. Americas Biologics CXO Services Value Market Share by Country in 2025
Figure 24. United States Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Biologics CXO Services Market Size Market Share by Region in 2025
Figure 29. APAC Biologics CXO Services Market Size Market Share by Type (2021-2026)
Figure 30. APAC Biologics CXO Services Market Size Market Share by Application (2021-2026)
Figure 31. China Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 35. India Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Biologics CXO Services Market Size Market Share by Country in 2025
Figure 38. Europe Biologics CXO Services Market Size Market Share by Type (2021-2026)
Figure 39. Europe Biologics CXO Services Market Size Market Share by Application (2021-2026)
Figure 40. Germany Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. France Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Biologics CXO Services Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Biologics CXO Services Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Biologics CXO Services Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 54. APAC Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 55. Europe Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 57. United States Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 58. Canada Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 59. Mexico Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 60. Brazil Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 61. China Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 62. Japan Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 63. Korea Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 65. India Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 66. Australia Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 67. Germany Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 68. France Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 69. UK Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 70. Italy Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 71. Russia Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 72. Egypt Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 73. South Africa Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 74. Israel Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 75. Turkey Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 76. Global Biologics CXO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Biologics CXO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 1. Biologics CXO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics CXO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biologics CXO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biologics CXO Services Sales Market Share by Country/Region (2025)
Figure 8. Biologics CXO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biologics CXO Services Market Size Market Share by Type in 2025
Figure 10. Biologics CXO Services in API CXO
Figure 11. Global Biologics CXO Services Market: API CXO (2021-2026) & ($ millions)
Figure 12. Biologics CXO Services in FDF CXO
Figure 13. Global Biologics CXO Services Market: FDF CXO (2021-2026) & ($ millions)
Figure 14. Biologics CXO Services in Other
Figure 15. Global Biologics CXO Services Market: Other (2021-2026) & ($ millions)
Figure 16. Global Biologics CXO Services Market Size Market Share by Application in 2025
Figure 17. Global Biologics CXO Services Revenue Market Share by Player in 2025
Figure 18. Global Biologics CXO Services Market Size Market Share by Region (2021-2026)
Figure 19. Americas Biologics CXO Services Market Size 2021-2026 ($ millions)
Figure 20. APAC Biologics CXO Services Market Size 2021-2026 ($ millions)
Figure 21. Europe Biologics CXO Services Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Biologics CXO Services Market Size 2021-2026 ($ millions)
Figure 23. Americas Biologics CXO Services Value Market Share by Country in 2025
Figure 24. United States Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Biologics CXO Services Market Size Market Share by Region in 2025
Figure 29. APAC Biologics CXO Services Market Size Market Share by Type (2021-2026)
Figure 30. APAC Biologics CXO Services Market Size Market Share by Application (2021-2026)
Figure 31. China Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 35. India Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Biologics CXO Services Market Size Market Share by Country in 2025
Figure 38. Europe Biologics CXO Services Market Size Market Share by Type (2021-2026)
Figure 39. Europe Biologics CXO Services Market Size Market Share by Application (2021-2026)
Figure 40. Germany Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. France Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Biologics CXO Services Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Biologics CXO Services Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Biologics CXO Services Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Biologics CXO Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 54. APAC Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 55. Europe Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 57. United States Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 58. Canada Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 59. Mexico Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 60. Brazil Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 61. China Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 62. Japan Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 63. Korea Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 65. India Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 66. Australia Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 67. Germany Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 68. France Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 69. UK Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 70. Italy Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 71. Russia Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 72. Egypt Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 73. South Africa Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 74. Israel Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 75. Turkey Biologics CXO Services Market Size 2027-2032 ($ millions)
Figure 76. Global Biologics CXO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Biologics CXO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Biologics CXO Services Market Size 2027-2032 ($ millions)
